HealthEquity, Inc.
$83.22
▼
-1.28%
2026-04-22 10:12:13
www.healthequity.com
NMS: HQY
Explore HealthEquity, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.04 B
Current Price
$83.22
52W High / Low
$116.65 / $72.76
Stock P/E
33.83
Book Value
$24.79
Dividend Yield
—
ROCE
10.16%
ROE
10.19%
Face Value
—
EPS
$2.46
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
2,814
Beta
0.26
Debt / Equity
47.53
Current Ratio
3.27
Quick Ratio
3.27
Forward P/E
14.6
Price / Sales
5.07
Enterprise Value
$7.27 B
EV / EBITDA
15.08
EV / Revenue
5.53
Rating
Buy
Target Price
$112.88
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | HeartBeam, Inc. | $0.92 | — | $37.8 M | — | -812.1% | -9.87% | $4 / $0.54 | $0.07 |
| 2. | 10x Genomics, Inc. | $24.59 | — | $3.14 B | — | -12.49% | -5.78% | $26.45 / $7.25 | $6.24 |
| 3. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 4. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 5. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 6. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 7. | Healthcare Triangle, Inc. | $2.47 | — | $4.86 M | — | 89.58% | -1.83% | $7,470 / $2.24 | $17.67 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|---|
| Sales | 334.59 M | 322.16 M | 325.83 M | 330.84 M | 311.82 M | — |
| Operating Profit | 72.39 M | 79.85 M | 90.88 M | 84.35 M | 44.33 M | — |
| Net Profit | 49.74 M | 51.69 M | 59.85 M | 53.91 M | 26.36 M | — |
| EPS in Rs | 0.59 | 0.61 | 0.71 | 0.64 | 0.31 | — |
Profit & Loss
Figures shown in M / B
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Sales | 1.31 B | 1.2 B | 999.59 M | 861.75 M |
| Operating Profit | 327.48 M | 202.87 M | 128.13 M | 37.65 M |
| Net Profit | 215.2 M | 96.7 M | 55.71 M | -26.14 M |
| EPS in Rs | 2.55 | 1.14 | 0.66 | -0.31 |
Balance Sheet
Figures shown in M / B
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Total Assets | 3.38 B | 3.45 B | 3.16 B | 3.09 B |
| Total Liabilities | 1.27 B | 1.33 B | 1.13 B | 1.19 B |
| Equity | 2.11 B | 2.11 B | 2.04 B | 1.9 B |
| Current Assets | 512.28 M | 477.75 M | 557.44 M | 382.89 M |
| Current Liabilities | 156.85 M | 156.32 M | 117.09 M | 131.06 M |
Cash Flow
Last available yearly cash flow history
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Operating CF | 457.09 M | 339.86 M | 242.83 M | 150.65 M |
| Investing CF | -47.14 M | -505.45 M | -46.07 M | -119.13 M |
| Financing CF | -386.98 M | 57.57 M | -47.04 M | -2.67 M |
| Free CF | 408.32 M | -165.6 M | 196.75 M | 31.52 M |
| Capex | -48.78 M | -505.45 M | -46.07 M | -119.13 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 20.03% | 16% | — | — |
| Earnings Growth % | 73.58% | 313.1% | — | — |
| Profit Margin % | 8.06% | 5.57% | -3.03% | — |
| Operating Margin % | 16.91% | 12.82% | 4.37% | — |
| Gross Margin % | 64.78% | 62.29% | 57.09% | — |
| EBITDA Margin % | 28.27% | 28.37% | 19.9% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.